Cronos Group Inc. CRON
3.72 USD +0.21 (+5.98%)
At closeNov 6, 2026, 6:36 AM EST
3.69 -0.03 -0.81%
Pre-market · Nov 6, 6:36 AM ET
3.61 Day range 3.91
2.28 52-week range 3.91
- YTD
- +41.44%
- 1 year
- +51.84%
- Market cap
- 1.37B
- Revenue (ttm)
- 179.09M
- Profit margin
- 39.08%
- EPS (ttm)
- 0.16
- Shares out
- 368.41M
- P/E ratio
- 23.25
- Forward P/E
- -87.75
- YTD return
- +41.44%
- 1-year return
- +51.84%
- Volume
- 3.92M
- Avg volume
- 1.14M
- Open
- 3.71
- Previous close
- 3.51
- Day's range
- 3.61 – 3.91
- 52-week range
- 2.28 – 3.91
- Beta
- 1.25
- Analysts
- Strong Buy
- Price target
- 3.02 (-18.8%)
- Earnings date
- Nov 5, 2026
5D +0.38 (+11.38%)
Key statistics
- Enterprise value
- 498.28M
- PEG ratio
- 0.00
- Price / sales
- 7.22
- Price / book
- 1.22
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 58.40%
- Free cash flow
- 6.11M
- Total cash
- 797.02M
- Total debt
- 1.29M
- Return on equity
- 7.05%
- Short % of float
- 2.17%
- 50-day average
- 3.30
- 200-day average
- 2.86
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 3.02
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy0
- Buy4
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.00.
Financials — quick view
CRON Revenue — quarterly 53.01M
CRON Net income — quarterly 32.09M
CRON EPS — quarterly 0.09
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 0.03 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.01 | 0.09 | +0.08 | +800.00% |
| May 11, 2026 | Mar 31, 2026 | 0.005 | 0.04 | +0.04 | +700.00% |
| Feb 26, 2026 | Dec 31, 2025 | 0.01 | -0.0047 | -0.01 | -147.00% |
| Nov 6, 2025 | Sep 30, 2025 | 0.02 | 0.07 | +0.05 | +250.00% |
| Aug 7, 2025 | Jun 30, 2025 | -0.02 | -0.10 | -0.08 | -400.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Zuanic & Associates | init | — | Overweight |
| May 15, 2024 | CIBC | main | Outperformer | Outperformer |
| Apr 8, 2024 | B of A Securities | main | Underperform | Underperform |
| Dec 28, 2023 | B of A Securities | main | Underperform | Underperform |
| May 15, 2023 | Barclays | main | Equal-Weight | Equal-Weight |
| Nov 2, 2022 | Bernstein | init | — | Market Perform |
About Cronos Group Inc.
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- Website
- thecronosgroup.com
News
Cronos Group (NASDAQ:CRON) Hits New 52-Week High After Strong Earnings
Cronos Group (CRON) Q3 Earnings and Revenues Beat Estimates Cronos Group Q3 EPS $0.04 Beats $0.03 Estimate, Sales $63.450M Beat $49.467M Estimate
Cronos Group Reports 2026 Third Quarter Results
Baker Hughes Wins Major Subsea Contract From Eni for Cronos Gas
This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Zuanic & Associates Initiates Coverage On Cronos Group with Overweight Rating
Your note
Sign in to keep a note on CRON — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Buggy (Shannon) | Senior Officer of Issuer | Grant of options | May 11, 2026 | 187,501 |
| Doucet (Terrence Gregory Joseph) | Senior Officer of Issuer | Grant of options | May 11, 2026 | 115,787 |
| Gorenstein (Michael Ryan) | Director of Issuer | Grant of options | Mar 14, 2026 | 13,340,723 |
| Jacobson (Jeffrey David) | Senior Officer of Issuer | Grant of options | Mar 14, 2026 | 507,233 |
| Kenost (Jared Matthew) | Senior Officer of Issuer | Grant of options | May 11, 2026 | 46,675 |
| Shlimak (Anna) | Senior Officer of Issuer | Grant of options | Mar 18, 2026 | 368,362 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Shaw D.E. & Co., Inc. | 2.41% | 8,840,503 | 31.03M | Jun 29, 2026 |
| Chescapmanager LLC | 2.17% | 7,942,737 | 27.88M | Jun 29, 2026 |
| Tidal Investments LLC | 1.03% | 3,767,849 | 13.23M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 0.83% | 3,048,254 | 10.70M | Jun 29, 2026 |
| Arrowstreet Capital, Limited Partnership | 0.54% | 1,992,855 | 6.99M | Jun 29, 2026 |
| Mackenzie Financial Corporation | 0.51% | 1,873,116 | 6.57M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Amplify ETF Trust-Amplify Alternative Harvest ETF | 0.99% | 3,638,889 | 12.77M | Jun 29, 2026 |
| DFA INVESTMENT TRUST CO-The Canadian Small Company Series | 0.25% | 917,712 | 3.22M | Jul 30, 2026 |
| DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT. | 0.24% | 877,349 | 3.08M | Jul 30, 2026 |
| iShares Trust-iShares Core MSCI Total International Stock ETF | 0.18% | 664,585 | 2.33M | Sep 29, 2026 |
| AdvisorShares Trust-AdvisorShares Pure Cannabis ETF | 0.14% | 503,020 | 1.77M | Sep 29, 2026 |
| Northern Lights Fund Trust IV-USA Mutuals Vice Fund | 0.13% | 480,000 | 1.68M | Jun 29, 2026 |
